Back to search

University of Ioannina

Association of arterial hypertension, diabetes mellitus and inflammation with cancer incidence and mortality

Abstract

dc:description

Cancer is a major public health problem worldwide and is the second leading cause of death. The latest version of the GLOBOCAN database (September 2018) predicts 18 million cancer cases and 9.6 million cancer deaths for 2018. The main objective of this work is to investigate possible associations between large categories of potential risk factors, namely hypertension, type 2 diabetes mellitus and inflammation, and the incidence of cancer. These questions were investigated through three separate studies: The first study used data from the European Prospective Cancer and Nutrition Study (EPIC) and examined the association of blood pressure with the risk of cancer in all anatomical sites. Risk factors (HRs) were estimated using Cox proportional hazards models for systolic blood pressure (SBP), diastolic blood pressure (SBP), mean arterial pressure (SBP), hypertension and antihypertensive treatment in hypertensive subjects. In addition, statistical interactions were tested according to age, gender, body mass index (BMI), smoking, alcohol intake and use of hypertension therapy. Finally, sensitivity analyzes were performed, excluding the first two years of follow-up. The study included 307,318 men and women, with an average follow-up of 13.7 (standard deviation 4.4) years and 39,298 incident cancers. We confirmed the expectedpositive association with renal cell carcinoma: HR=1.12 (1.08–1.17) per 10mm Hg higher SBP andHR=1.23(1.14–1.32) for DBP. We additionally found positive associations for esophageal squamous cell carcinoma (SCC): HR=1.16 (1.07–1.26) (SBP), HR=1.31 (1.13–1.51) (DBP), weaker for head and neck cancers: HR=1.08 (1.04–1.12) (SBP), HR=1.09 (1.01–1.17) (DBP) and, similarly, for skin SCC, colon cancer, postmenopausal breast cancer and uterine adenocarcinoma (AC). We observed weak inverse associations of SBP with cervical SCC: HR=0.91 (0.82–1.00) and lymphomas: HR=0.97(0.93–1.00). There were no consistent associations with cancers in other locations. Our results are largely compatible with published studies and support weak associations of blood pressure with cancers in specific locations and morphologies. The second study summarized and evaluated the validity of the literature regarding the association of type 2 diabetes (T2DM) with the risk of developing or dying from cancer using the umbrella review methodology. Summary effect and 95% confidence intervals were calculated using both fixed and random effects inverse variants weighted methods. In addition, we assessed the heterogeneity between studies with the Cochran’s Q test and the I2 metric of inconsistency, as well as the methodological quality of all metaanalyzes included in this study using the AMSTAR tool, an 11-item questionnaire summarizing the positive responses to achieve an overall quality score. Finally, an additional review of Mendelian randomization studies that evaluated whether genetically predicted probability of T2DM and levels of fasting insulin, glucose and glycosylated hemoglobin (HbA1C) was associated with risk of cancer. We found eligible observational meta-analyses that assessed associations between T2DM and cancer incidence in 18 cancer sites/sub-sites, cancer mortality in seven cancer sites, and cancer incidence or mortality in four cancer sites. The summary random effect estimates were significant at P≤0.05 in 23 meta-analyses (79%). When assessing study quality and evidence grade, studies of six cancer-sites did not have substantial heterogeneity and had strong or highly suggestive evidence of association with incident cancers, namely colorectal, hepatocellular, gallbladder, pancreatic, breast and endometrial cancer. Furthermore, we found four studies assessing the potential causaleffect of T2DM and six studies assessing the potential causal effect of fasting insulin or fasting glucose upon site-specific cancers. No causal effect was found between genetically predicted T2DM or fasting glucose and cancers, except fasting glucose and squamous cell lung carcinoma, whereas genetically predicted fasting insulin was causally associated with an increased risk of breast, endometrial, pancreatic and renal cancers. In conclusion, we found strong evidence for the association between T2DM and various cancers. In the third study, data from the CLUE II cohort were used and the possible association between inflammation and colorectal cancer was examined by evaluating the circulating concentrations of interleukin6 (IL-6). Specifically, matched odds ratios and the corresponding 95 % confidence intervals (CIs) were estimated using conditional logistic regression models in a nested case-control study. In addition, the validity of the literature was evaluated through a meta-analysis of prospective epidemiological studies in order to summarize all bibliographic evidence and study its heterogeneity. Participants in the highest third of plasma IL-6 concentration had a 2.48 times higher risk of colon cancer compared to participants in the bottom third (95 % CI 1.26–4.87; p-trend 0.02) after multivariate adjustment. This association did not differ according to the stage of disease, age, sex, or other potential modifying variables and remained statistically significant after adjustment for C-reactive protein concentrations. No statistically significant association was observed for rectal cancer risk. The meta-analysis of six prospective studies yielded an increased but borderline statistically significant risk of colon cancer per 1 unit increase in naturally logarithm transformed IL-6 (summary RR 1.22; 95 % CI 1.00–1.49; I2 46 %). An inverse association was noted for rectal cancer (RR 0.69; 95 % CI 0.54–0.88; I20 %), but there was evidence for small study effects (P 0.02). The findings provide support for amodest positive association between IL-6 concentrations and colon cancer risk. More work is needed to determine whether IL-6 is a valid marker of colorectal inflammation and whether such inflammation contributes to colon and rectal cancer risk.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kakourou, Artemisia
  • Κακούρου, Αρτεμισία

Subjects

dc:subject × 18

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48143

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kakourou, Artemisia; Κακούρου, Αρτεμισία. Association of arterial hypertension, diabetes mellitus and inflammation with cancer incidence and mortality. University of Ioannina, 2020. http://hdl.handle.net/10442/hedi/48143